CVS has a new clinical trials business, and it will have no trouble recruiting participants

CVS Health launched a new clinical trials business, Clinical Trial Services, which will provide research solutions to drug developers and contract research organizations (CROs).

  • Using its nationwide retail footprint, it plans to: reach more eligible participants, administer study-related tests (both at home, virtually, or at a CVS site) and foster diversity in recruiting to ensure that essays better reflect the real world. populations.

This is not surprising news – CVS has already made inroads into clinical trials:

  • CVS has played a major role in bolstering COVID-19 clinical trials in the United States. He worked with five Operation Warp Speed ​​clinical trial sponsors and other industry partners to quickly recruit a diverse pool of COVID-19 clinical trial participants using its digital models and data-driven screening protocols.
  • And CVS has relied on its specialized infusion services and enteral nutrition business line Coram to help decentralize clinical trials in the past. For context, infusion services involve the provision of intravenous drug therapy – examples include chemotherapy, pain management, and antibiotic treatments. Coram has designed tailor-made solutions for drugmakers and CRO customers using home care and project management services to optimize their clinical trials by administering patient home study-related procedures: for example, for one study, Coram achieved a patient retention rate close to 90%—Well above 70% average rate.
  • Even in 2019, CVS launched its clean clinical trial to study its Hemocare hemodialysis system. The trial was designed to prove the safety and viability of CVS’s home hemodialysis device, which would allow patients to receive regular treatment for kidney disease without the need for frequent in-person visits.

With major players like Current Health and Komodo Health on their knees in the clinical trials space, CVS has the cards in its favor – it has companies across the pharmaceutical supply chain to lean on. for recruitment.

  • Clinical trials are key to proving the safety and effectiveness of new drugs, but recruiting and retaining participants prevents many from concluding successfully. For example, 80% of studies do not meet participant registration deadlines, and approximately 30% of participants drop out before the end of a study for reasons ranging from inconvenient site location, complex participation requirements and trial length.
  • CVS is uniquely positioned to drive clinical trial recruitment and retention by leveraging its broad customer base across its pharmacy benefits manager, retail pharmacies and insurance business. CVS already has huge amounts of patient data to find and capture patients eligible for clinical trials: for example, CVS Pharmacy stores serve 4.5 million patients daily, and Aetna serves around 40 million members. Add, more than 75% of people in the United States live within 3 miles of a CVS store, which it can rely on to improve accessibility of clinical trials: 38% of patients who dropped out of a trial said the on-site visits were stressful, citing inconvenient time and place conflicts as the main reasons for dropping out.

About Terry Gongora

Check Also

Protecting Maternal Health in Rwanda | MIT News

The world faces a maternal health crisis. According to the World Health Organization, about 810 …

Leave a Reply

Your email address will not be published.